Vetoquinol SA Q1 2026: Strong Diagnostics Growth, Flat Core Sales & Investor Confidence
Vetoquinol SA’s 2025 filing and Q1 2026 sales data reveal steady core growth, strategic portfolio simplification, and new diagnostic opportunities—insights for investors.
3 minutes to read